{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:04:04Z","timestamp":1778767444973,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["BMBF 03ZIK\/OncoRay"],"award-info":[{"award-number":["BMBF 03ZIK\/OncoRay"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["DFG Ba 1433\/5"],"award-info":[{"award-number":["DFG Ba 1433\/5"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.radonc.2016.07.024","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T10:01:57Z","timestamp":1482141717000},"page":"447-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours"],"prefix":"10.1016","volume":"121","author":[{"given":"Christina","family":"Jentsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Br\u00fcchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Mosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala","family":"Yaromina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Thames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Beuthien-Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.07.024_b0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y","article-title":"The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma","volume":"83","author":"Ahuja","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.07.024_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","article-title":"Clinical role of positron emission tomography in oncology","volume":"2","author":"Bomanji","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hed.10037","article-title":"FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma","volume":"24","author":"Brun","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.07.024_b0020","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.07.024_b0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00005537-200009000-00016","article-title":"Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient","volume":"110","author":"Lonneux","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.07.024_b0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.semnuclmed.2005.05.001","article-title":"Update on 18F-fluorodeoxyglucose\/positron emission tomography and positron emission tomography\/computed tomography imaging of squamous head and neck cancers","volume":"35","author":"Menda","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.radonc.2016.07.024_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.radonc.2009.01.003","article-title":"Is pre-therapeutical FDG-PET\/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?","volume":"91","author":"Abramyuk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2009.03.006","article-title":"Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan","volume":"91","author":"Aerts","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0045","first-page":"1907","article-title":"Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer","volume":"38","author":"Minn","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2016.07.024_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2006.07.033","article-title":"Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients","volume":"80","author":"Thorwarth","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2016.07.024_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijrobp.2007.06.039","article-title":"Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study","volume":"70","author":"Lee","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archoto.2009.152","article-title":"Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography","volume":"135","author":"Malone","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2016.07.024_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.07.019","article-title":"Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report","volume":"74","author":"Yao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2016.07.024_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2407-13-84","article-title":"Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer","volume":"13","author":"Heukelom","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2016.07.024_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2012.03.005","article-title":"The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer","volume":"104","author":"van Elmpt","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2007.04.033","article-title":"Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice","volume":"83","author":"Schutze","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2006.08.010","article-title":"Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies","volume":"81","author":"Yaromina","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0360-3016(92)90653-Y","article-title":"Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation","volume":"23","author":"Baumann","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0105","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2003.12.039","article-title":"Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose","volume":"59","author":"Allal","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/09553000903039180","article-title":"Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy","volume":"85","author":"Hentschel","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2016.07.024_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1470-2045(09)70353-5","article-title":"PET-CT for response assessment and treatment adaptation in head and neck cancer","volume":"11","author":"Bussink","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2006.01.006","article-title":"Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies","volume":"78","author":"Geets","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006\u20132007","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2006.09.011","article-title":"Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives","volume":"81","author":"Nestle","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2007.05.010","article-title":"Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy","volume":"85","author":"Geets","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.radonc.2009.09.010","article-title":"Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers","volume":"93","author":"de Figueiredo","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.024_b0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijrobp.2005.02.009","article-title":"Dependence of FDG uptake on tumor microenvironment","volume":"62","author":"Pugachev","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0160","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/ijc.23449","article-title":"Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia","volume":"122","author":"Busk","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2016.07.024_b0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/09553000903043067","article-title":"Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation","volume":"85","author":"Bruechner","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2016.07.024_b0170","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-0290","article-title":"Preclinical assessment of efficacy of radiation dose painting based on intratumoral FDG-PET uptake","author":"Trani","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.07.024_b0175","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.02.015","article-title":"Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts","volume":"80","author":"Yaromina","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.024_b0180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00066-011-2210-1","article-title":"Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control","volume":"187","author":"Zips","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.07.024_b0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2307\/3577740","article-title":"Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units","volume":"123","author":"Baumann","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2016.07.024_b0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004728-197906000-00001","article-title":"Quantitation in positron emission computed tomography: 1. Effect of object size","volume":"3","author":"Hoffman","year":"1979","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.radonc.2016.07.024_b0195","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004728-198406000-00028","article-title":"Analysis of emission tomographic scan data: limitations imposed by resolution and background","volume":"8","author":"Kessler","year":"1984","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.radonc.2016.07.024_b0200","first-page":"1836","article-title":"SUV: standard uptake or silly useless value?","volume":"36","author":"Keyes","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2016.07.024_b0205","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1088\/0031-9155\/61\/8\/3084","article-title":"Precise image-guided irradiation of small animals: a flexible non-profit platform","volume":"61","author":"Tillner","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2016.07.024_b0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/humu.20813","article-title":"Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases","volume":"30","author":"Mitchell","year":"2009","journal-title":"Hum Mutat"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016312403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016312403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T09:22:57Z","timestamp":1656235377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016312403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0167814016312403"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.07.024","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}